Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
About us
People
Ida Neldemo

Ida Neldemo

Ida Neldemo, Ph.D.

Senior Director, MIDD Consultant

Google scholar

Joined Pharmetheus in 2019, actively working in client projects and with continuous improvements
Expertise includes pharmacometrics, pediatrics, and trial design in therapeutic areas such as oncology
Previously worked as temporary Consultant at Pharmetheus, where she worked with hands-on application of pharmacometric approaches to support drug development
M.Sc in Pharmacy (2013) and Ph.D in Pharmaceutical Sciences (2019) from Uppsala University, Sweden

Pharmetheus affiliated publications

Model-informed pediatric drug development for clevidipine Dose Modifications in Exposure-Response Analyses of Oncology Drug Development: Brigimadlin Case Study Population pharmacokinetic analysis of doxecitine and doxribtimine in patients with thymidine kinase 2 deficiency and in healthy volunteers Exposure‐tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selection Application of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II study A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Science & Services
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Whistleblower
Privacy Policy
Cookie Policy